Skip to Content

Clinical Trial Details

RE-CIRCUIT

Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT)

Purpose/Objective

Request Additional Trial Information
Full Trial Details: ClinicalTrials.gov

Condition: Atrial Fibrillation
Study Type: Interventional
Phase: Phase IV
Study Start Date: 02/03/2016
Study Completion Date: 05/31/2017

This study is to assess the safety of an uninterrupted dabigatran etexilate periprocedural anticoagulant regimen compared to an uninterrupted warfarin regimen in NVAF patients undergoing AF ablation.

NCT Number
NCT02348723
Principal Investigator(s)
Sean Beinart, MD
Sponsor(s)
Boehringer Ingelheim
Participant Eligibility
  • Age: 18 - No Maximum
  • Gender: Male, Female

Location

  • Adventist HealthCare Washington Adventist Hospital
    7600 Carroll Avenue
    Takoma Park, MD 20912
    Main: 301-891-7600

Clincal Trials & Research Studies

Patient Stories

We’re writing new chapters in the lives of our patients, their families and our community daily. These are their stories:

Local Health News - In Your Inbox

Join over 40k of your friends & neighbors and get the latest news about community health programs and events when you sign-up for Adventist HealthCare & You Digital.

Subscribe Today!